NEW DRUG FOR MISMATCH REPAIR DEFICIENT ENDOMETRIAL CANCER AND SOLID TUMORS

被引：0
|
作者：
Aschenbrenner, Diane S. [1 ,2 ]
机构：
[1] Notre Dame Maryland Univ, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21218 USA
来源：
AMERICAN JOURNAL OF NURSING | 2021年 / 121卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
引用
收藏
页码：23 / 23
页数：1
相关论文
共 50 条
  • [31] Genotype Directed Therapy in Murine Mismatch Repair Deficient Tumors
    Kucherlapati, Melanie H.
    Esfahani, Shadi
    Habibollahi, Peiman
    Wang, Junning
    Still, Eric R.
    Bronson, Roderick T.
    Mahmood, Umar
    Kucherlapati, Raju S.
    PLOS ONE, 2013, 8 (07):
  • [32] Safety and efficacy of neoadjuvant pembrolizumab in mismatch repair deficient localized/locally advanced solid tumors.
    Ludford, Kaysia
    Raghav, Kanwal Pratap Singh
    Murphy, Mariela A. Blum
    Fleming, Nicole D.
    Nelson, Douglas A.
    Lee, Michael Sangmin
    Smaglo, Brandon George
    You, Y. Nancy
    Tillman, Matthew Murray
    Kamiya-Matsuoka, Carlos
    Thirumurthi, Selvi
    Messick, Craig
    Johnson, Benny
    Sanchez, Eduardo Vilar
    Dasari, Arvind
    Thomas, Jane V.
    Foo, Wai Chin
    Qiao, Wei
    Kopetz, Scott
    Overman, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] Mismatch repair and drug responses in cancer
    Sedwick, WD
    Markowitz, SD
    Veigl, ML
    DRUG RESISTANCE UPDATES, 1999, 2 (05) : 295 - 306
  • [34] Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study
    Eerkens, Anneke L.
    Brummel, Koen
    Vledder, Annege
    Paijens, Sterre T.
    Requesens, Marta
    Loiero, Dominik
    van Rooij, Nienke
    Plat, Annechien
    Haan, Floris-Jan
    Klok, Patty
    Yigit, Refika
    Roelofsen, Thijs
    de Lange, Natascha M.
    Klomp, Rie
    Church, David
    ter Elst, Arja
    Wardenaar, Rene
    Spierings, Diana
    Foijer, Floris
    Koelzer, Viktor Hendrik
    Bosse, Tjalling
    Bart, Joost
    Jalving, Mathilde
    Reyners, Anna K. L.
    de Bruyn, Marco
    Nijman, Hans W.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [35] Mismatch Repair Protein Status of Endometrial Hyperplasia in Cases with Concomitant MMR Deficient Endometrial Carcinoma
    Smithgall, Marie
    Tu, Jiangling
    Yemelyanova, Anna
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 830 - 830
  • [36] Mismatch Repair Protein Status of Endometrial Hyperplasia in Cases with Concomitant MMR Deficient Endometrial Carcinoma
    Smithgall, Marie
    Tu, Jiangling
    Yemelyanova, Anna
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 830 - 830
  • [37] Endometrial cancer associated with defective DNA mismatch repair
    Soliman, Pamela T.
    Lu, Karen
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2007, 34 (04) : 701 - +
  • [38] Spatial profiling of mismatch repair deficient endometrial tumors identifies patterns associated with recurrence and response to immune checkpoint therapy
    Hermann, Catherine
    Hollenberg, Michelle
    Katsnelson, Lizabeth
    Liu, Wenke
    Tan, Jimin
    Adler, Esther
    Selvaraj, Priya
    Loomis, Cynthia
    Boyd, Leslie
    Fenyo, David
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S226 - S226
  • [39] Clinicopathologic features of endometrial cancer with mismatch repair deficiency
    Gordhandas, Sushmita
    Kahn, Ryan M.
    Gamble, Charlotte
    Talukdar, Nizam
    Maddy, Brandon
    Nelson, Becky Baltich
    Askin, Gulce
    Christos, Paul J.
    Holcomb, Kevin
    Caputo, Thomas A.
    Chapman-Davis, Eloise
    Frey, Melissa K.
    ECANCERMEDICALSCIENCE, 2020, 14
  • [40] Immune checkpoint inhibitor response in mismatch repair-deficient colorectal cancer and other solid tumors: is it truly disease-agnostic?
    Sahin, Ibrahim Halil
    COLORECTAL CANCER, 2020, 9 (04)
12345